ReviewRheumatology international2016

Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?

Sujani Yadlapati et al.PubMed ↗Publisher ↗

No numbers read from the abstract.